How M.D. was paid
$3.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Incentive | Other | Total |
|---|---|---|---|---|---|
| Mihael H. Polymeropoulos, M.D.President, Chief Executive Officer and Chairman of the Board | $965,655 | $2,007,000 | $834,326 | $44,487 | $3,851,468 |
| Kevin MoranSenior Vice President, Chief Financial Officer and Treasurer | $559,935 | $557,500 | $272,129 | $50,096 | $1,439,660 |
| Gunther BirznieksSenior Vice President, Business Development | $559,935 | $557,500 | $272,129 | $25,907 | $1,415,471 |
| Joakim WijkstromSenior Vice President, Chief Marketing Officer | $579,600 | $557,500 | $281,686 | $38,742 | $1,457,528 |
| Timothy WilliamsSenior Vice President, General Counsel and Secretary | $559,935 | $557,500 | $272,129 | $55,405 | $1,444,969 |
What changed and why
- $3.9MCEO total compensation decreased slightly to $3,851,468 in 2025 from $3,896,241 in 2024.
- $216.1MTotal revenues reached $216.1 million alongside a net loss of $220.5 million.
- 108%Annual cash incentive bonuses were earned at 108% of target for NEOs.
- Performance-based RSUs were introduced for executive long-term incentives beginning in 2026.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.